Unsupported off-label chemotherapy in metastatic colon cancer

BACKGROUND: Newer systemic therapies have the potential to decrease morbidity and mortality from metastatic colorectal cancer, yet such therapies are costly and have side effects. Little is known about their non-evidence-based use. METHODS: We conducted a retrospective cohort study using commercial...

Descripción completa

Detalles Bibliográficos
Autores principales: de Souza, Jonas A, Polite, Blase, Perkins, Monica, Meropol, Neal J, Ratain, Mark J, Newcomer, Lee N, Alexander, G Caleb
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544564/
https://www.ncbi.nlm.nih.gov/pubmed/23272659
http://dx.doi.org/10.1186/1472-6963-12-481

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544564/
https://www.ncbi.nlm.nih.gov/pubmed/23272659
http://dx.doi.org/10.1186/1472-6963-12-481

Ejemplares similares